This report details the clinical progress of a 32-year-old female patient who presented with post-traumatic neuropathy of the ulnar and radial nerves following an injury to her left forearm.
Prior to beginning treatment, the patient reported persistent numbness in her left arm and hand, with the symptoms most pronounced in the elbow and fingers. She experienced regular pain and numbness, particularly when performing tasks requiring the use of a knife.
The patient’s medical history indicates that three months prior to her initial consultation, she suffered a fall from a chair at home, resulting in significant swelling of the arm. Upon visiting the emergency room, she was diagnosed with a bruise of the left forearm and hand and was prescribed painkillers. While the swelling subsided and the pain diminished between the fourth and sixth days following the injury, the underlying neuropathy persisted. Notably, the patient did not present with any deterioration of concomitant pathologies prior to starting her treatment at the center.
The patient underwent a course of 11 daily coMra therapy treatments. Throughout this period, she also received four sessions of EHF therapy and massage focused on the left arm, the collar area, and the thoracic spine. During the course of this treatment, the patient did not require any additional medical examinations or the use of painkillers.
The results of the treatment were significant. The patient reported that the pain in her hand and the numbness in her fingers had completely resolved. Furthermore, she noted improved flexibility in the elbow joint.
Upon clinical examination following the treatment, it was determined that the patient’s range of motion had recovered to 80–90% across all planes, a substantial improvement from the 50–55% range observed prior to the intervention.
Following the conclusion of the treatment course, the patient was advised to undergo a follow-up examination to clarify the specific area and depth of damage to the nerve plexus fibers. She was also recommended to continue coMra therapy after a two-to-three-week rest period, depending on her ongoing condition.